vs
景顺（IVZ）与SELECT MEDICAL HOLDINGS CORP（SEM）财务数据对比。点击上方公司名可切换其他公司
景顺的季度营收约是SELECT MEDICAL HOLDINGS CORP的1.2倍（$1.7B vs $1.4B），SELECT MEDICAL HOLDINGS CORP净利率更高（1.4% vs -58.9%，领先60.3%），SELECT MEDICAL HOLDINGS CORP同比增速更快（6.4% vs 6.2%），景顺自由现金流更多（$432.2M vs $5.2M），过去两年景顺的营收复合增速更高（7.1% vs 2.8%）
景顺是总部位于美国佐治亚州亚特兰大的独立投资管理企业，在全球20个国家设有分支机构，旗下运营景顺、Invesco Perpetual、PowerShares等品牌，普通股为标普500指数成分股，于纽约证券交易所挂牌交易。
Select Medical是总部位于美国宾夕法尼亚州的医疗健康企业，业务涵盖长期急症护理、住院康复医院运营，同时开设有职业健康与物理治疗诊所，母公司Select Medical Holdings在纽约证券交易所挂牌上市。
IVZ vs SEM — 直观对比
营收规模更大
IVZ
是对方的1.2倍
$1.4B
营收增速更快
SEM
高出0.2%
6.2%
净利率更高
SEM
高出60.3%
-58.9%
自由现金流更多
IVZ
多$427.0M
$5.2M
两年增速更快
IVZ
近两年复合增速
2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $1.4B |
| 净利润 | $-995.9M | $20.2M |
| 毛利率 | — | — |
| 营业利润率 | -86.2% | 4.6% |
| 净利率 | -58.9% | 1.4% |
| 营收同比 | 6.2% | 6.4% |
| 净利润同比 | -575.8% | 225.7% |
| 每股收益（稀释后） | $-2.61 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IVZSEM
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.5B | $1.3B | ||
| Q1 24 | $1.5B | $1.3B |
净利润IVZSEM
| Q4 25 | $-995.9M | $20.2M | ||
| Q3 25 | $356.4M | $28.8M | ||
| Q2 25 | $197.4M | $40.6M | ||
| Q1 25 | $171.1M | $56.7M | ||
| Q4 24 | $209.3M | $-16.1M | ||
| Q3 24 | $55.0M | $55.6M | ||
| Q2 24 | $132.2M | $77.6M | ||
| Q1 24 | $141.5M | $96.9M |
营业利润率IVZSEM
| Q4 25 | -86.2% | 4.6% | ||
| Q3 25 | 16.5% | 5.4% | ||
| Q2 25 | 14.1% | 6.5% | ||
| Q1 25 | 18.1% | 8.3% | ||
| Q4 24 | 19.6% | 1.6% | ||
| Q3 24 | 6.6% | 4.3% | ||
| Q2 24 | 13.9% | 5.8% | ||
| Q1 24 | 14.4% | 9.0% |
净利率IVZSEM
| Q4 25 | -58.9% | 1.4% | ||
| Q3 25 | 21.7% | 2.1% | ||
| Q2 25 | 13.0% | 3.0% | ||
| Q1 25 | 11.2% | 4.2% | ||
| Q4 24 | 13.1% | -1.2% | ||
| Q3 24 | 3.6% | 4.4% | ||
| Q2 24 | 8.9% | 6.1% | ||
| Q1 24 | 9.6% | 7.3% |
每股收益（稀释后）IVZSEM
| Q4 25 | $-2.61 | $0.17 | ||
| Q3 25 | $0.66 | $0.23 | ||
| Q2 25 | $-0.03 | $0.32 | ||
| Q1 25 | $0.38 | $0.44 | ||
| Q4 24 | $0.46 | $-0.12 | ||
| Q3 24 | $0.12 | $0.43 | ||
| Q2 24 | $0.29 | $0.60 | ||
| Q1 24 | $0.31 | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $26.5M |
| 总债务越低越好 | $1.8B | $1.8B |
| 股东权益账面价值 | $12.2B | $1.7B |
| 总资产 | $27.1B | $5.9B |
| 负债/权益比越低杠杆越低 | 0.15× | 1.06× |
8季度趋势，按日历期对齐
现金及短期投资IVZSEM
| Q4 25 | $1.0B | $26.5M | ||
| Q3 25 | $973.1M | $60.1M | ||
| Q2 25 | $922.7M | $52.3M | ||
| Q1 25 | $821.7M | $53.2M | ||
| Q4 24 | $986.5M | $59.7M | ||
| Q3 24 | $1.0B | $191.5M | ||
| Q2 24 | $878.5M | $111.2M | ||
| Q1 24 | $895.7M | $92.6M |
总债务IVZSEM
| Q4 25 | $1.8B | $1.8B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.9B | $1.8B | ||
| Q1 25 | $964.8M | $1.8B | ||
| Q4 24 | $890.6M | $1.7B | ||
| Q3 24 | $890.3M | $3.1B | ||
| Q2 24 | $890.1M | $3.6B | ||
| Q1 24 | $1.3B | $3.8B |
股东权益IVZSEM
| Q4 25 | $12.2B | $1.7B | ||
| Q3 25 | $14.0B | $1.7B | ||
| Q2 25 | $13.9B | $1.7B | ||
| Q1 25 | $14.7B | $1.7B | ||
| Q4 24 | $14.6B | $1.7B | ||
| Q3 24 | $14.8B | $1.9B | ||
| Q2 24 | $14.6B | $1.4B | ||
| Q1 24 | $14.6B | $1.4B |
总资产IVZSEM
| Q4 25 | $27.1B | $5.9B | ||
| Q3 25 | $28.4B | $5.7B | ||
| Q2 25 | $28.5B | $5.7B | ||
| Q1 25 | $28.1B | $5.7B | ||
| Q4 24 | $27.0B | $5.6B | ||
| Q3 24 | $27.5B | $8.0B | ||
| Q2 24 | $27.2B | $7.9B | ||
| Q1 24 | $28.1B | $7.9B |
负债/权益比IVZSEM
| Q4 25 | 0.15× | 1.06× | ||
| Q3 25 | 0.12× | 1.03× | ||
| Q2 25 | 0.14× | 1.10× | ||
| Q1 25 | 0.07× | 1.03× | ||
| Q4 24 | 0.06× | 1.01× | ||
| Q3 24 | 0.06× | 1.62× | ||
| Q2 24 | 0.06× | 2.54× | ||
| Q1 24 | 0.09× | 2.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $455.8M | $64.3M |
| 自由现金流经营现金流 - 资本支出 | $432.2M | $5.2M |
| 自由现金流率自由现金流/营收 | 25.5% | 0.4% |
| 资本支出强度资本支出/营收 | 1.4% | 4.2% |
| 现金转化率经营现金流/净利润 | — | 3.19× |
| 过去12个月自由现金流最近4个季度 | $1.4B | $117.2M |
8季度趋势，按日历期对齐
经营现金流IVZSEM
| Q4 25 | $455.8M | $64.3M | ||
| Q3 25 | $606.2M | $175.3M | ||
| Q2 25 | $547.9M | $110.3M | ||
| Q1 25 | $-84.6M | $-3.5M | ||
| Q4 24 | $316.9M | $125.4M | ||
| Q3 24 | $438.4M | $181.0M | ||
| Q2 24 | $489.1M | $278.2M | ||
| Q1 24 | $-54.4M | $-66.7M |
自由现金流IVZSEM
| Q4 25 | $432.2M | $5.2M | ||
| Q3 25 | $586.4M | $122.2M | ||
| Q2 25 | $530.4M | $45.6M | ||
| Q1 25 | $-108.0M | $-55.8M | ||
| Q4 24 | $309.9M | $62.0M | ||
| Q3 24 | $410.0M | $130.3M | ||
| Q2 24 | $462.4M | $222.6M | ||
| Q1 24 | $-75.4M | $-119.2M |
自由现金流率IVZSEM
| Q4 25 | 25.5% | 0.4% | ||
| Q3 25 | 35.7% | 9.0% | ||
| Q2 25 | 35.0% | 3.4% | ||
| Q1 25 | -7.1% | -4.1% | ||
| Q4 24 | 19.5% | 4.7% | ||
| Q3 24 | 27.1% | 10.2% | ||
| Q2 24 | 31.2% | 17.4% | ||
| Q1 24 | -5.1% | -9.0% |
资本支出强度IVZSEM
| Q4 25 | 1.4% | 4.2% | ||
| Q3 25 | 1.2% | 3.9% | ||
| Q2 25 | 1.2% | 4.8% | ||
| Q1 25 | 1.5% | 3.9% | ||
| Q4 24 | 0.4% | 4.8% | ||
| Q3 24 | 1.9% | 4.0% | ||
| Q2 24 | 1.8% | 4.3% | ||
| Q1 24 | 1.4% | 4.0% |
现金转化率IVZSEM
| Q4 25 | — | 3.19× | ||
| Q3 25 | 1.70× | 6.09× | ||
| Q2 25 | 2.78× | 2.72× | ||
| Q1 25 | -0.49× | -0.06× | ||
| Q4 24 | 1.51× | — | ||
| Q3 24 | 7.97× | 3.25× | ||
| Q2 24 | 3.70× | 3.59× | ||
| Q1 24 | -0.38× | -0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IVZ
| Investment Advice | $1.2B | 73% |
| Distribution And Shareholder Service | $382.7M | 23% |
| Financial Service Other | $51.0M | 3% |
| Investment Performance | $28.9M | 2% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
